Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)

Abstract Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ha-Young Rhim, Sae-Yeon Won, Sepide Kashefiolasl, Nina Brawanski, Elke Hattingen, Joachim Berkefeld, Volker Seifert, Juergen Konczalla
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/3572470a69a84d839cac779f9f390e52
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3572470a69a84d839cac779f9f390e52
record_format	dspace
spelling	oai:doaj.org-article:3572470a69a84d839cac779f9f390e522021-12-02T14:27:56ZMultidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)10.1038/s41598-021-87863-y2045-2322https://doaj.org/article/3572470a69a84d839cac779f9f390e522021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87863-yhttps://doaj.org/toc/2045-2322Abstract Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center retrospective analysis of SAH cases involving patients treated in the neuro-ICU was performed. The outcome was assessed 6 months after SAH using the modified Rankin Scale [mRS, favorable (0–2) and unfavorable (3–6)]. Data were compared by matched-pair analysis. Patient characteristics were well matched in the MDRO (n = 61) and control (n = 61) groups. In this center, one nurse was assigned to a two-bed room. If a MDRO was detected, the patient was isolated, and the nurse was assigned to the patient infected with the MDRO. In the MDRO group, 29 patients (48%) had a favorable outcome, while 25 patients (41%) in the control group had a favorable outcome; the difference was not significant (p > 0.05). Independent prognostic factors for unfavorable outcomes were worse status at admission (OR = 3.1), concomitant intracerebral hematoma (ICH) (OR = 3.7), and delayed cerebral ischemia (DCI) (OR = 6.8). Infection with MRDOs did not have a negative impact on the outcome in SAH patients. Slightly better outcomes were observed in SAH patients infected with MDROs, suggesting the benefit of individual care.Ha-Young RhimSae-Yeon WonSepide KashefiolaslNina BrawanskiElke HattingenJoachim BerkefeldVolker SeifertJuergen KonczallaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ha-Young Rhim Sae-Yeon Won Sepide Kashefiolasl Nina Brawanski Elke Hattingen Joachim Berkefeld Volker Seifert Juergen Konczalla Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
description	Abstract Patient care in a neurointensive care unit (neuro-ICU) is challenging. Multidrug-resistant organisms (MDROs) are increasingly common in the routine clinical practice. We evaluated the impact of infection with MDROs on outcomes in patients with subarachnoid hemorrhage (SAH). A single-center retrospective analysis of SAH cases involving patients treated in the neuro-ICU was performed. The outcome was assessed 6 months after SAH using the modified Rankin Scale [mRS, favorable (0–2) and unfavorable (3–6)]. Data were compared by matched-pair analysis. Patient characteristics were well matched in the MDRO (n = 61) and control (n = 61) groups. In this center, one nurse was assigned to a two-bed room. If a MDRO was detected, the patient was isolated, and the nurse was assigned to the patient infected with the MDRO. In the MDRO group, 29 patients (48%) had a favorable outcome, while 25 patients (41%) in the control group had a favorable outcome; the difference was not significant (p > 0.05). Independent prognostic factors for unfavorable outcomes were worse status at admission (OR = 3.1), concomitant intracerebral hematoma (ICH) (OR = 3.7), and delayed cerebral ischemia (DCI) (OR = 6.8). Infection with MRDOs did not have a negative impact on the outcome in SAH patients. Slightly better outcomes were observed in SAH patients infected with MDROs, suggesting the benefit of individual care.
format	article
author	Ha-Young Rhim Sae-Yeon Won Sepide Kashefiolasl Nina Brawanski Elke Hattingen Joachim Berkefeld Volker Seifert Juergen Konczalla
author_facet	Ha-Young Rhim Sae-Yeon Won Sepide Kashefiolasl Nina Brawanski Elke Hattingen Joachim Berkefeld Volker Seifert Juergen Konczalla
author_sort	Ha-Young Rhim
title	Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
title_short	Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
title_full	Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
title_fullStr	Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
title_full_unstemmed	Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
title_sort	multidrug-resistant organisms (mdros) in patients with subarachnoid hemorrhage (sah)
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/3572470a69a84d839cac779f9f390e52
work_keys_str_mv	AT hayoungrhim multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT saeyeonwon multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT sepidekashefiolasl multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT ninabrawanski multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT elkehattingen multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT joachimberkefeld multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT volkerseifert multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah AT juergenkonczalla multidrugresistantorganismsmdrosinpatientswithsubarachnoidhemorrhagesah
_version_	1718391243351785472

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)

Ejemplares similares